Home › Funds › Lynx1 Capital Management LP › PASG

Lynx1 Capital Management LP position in PASG

Passage Bio Inc · Health Care

Lynx1 Capital Management LP reported holding 673,759 shares of PASG (Passage Bio Inc) in its Q2 2026 13F filing — a position valued at US$3.3M, representing 0.38% of its reported portfolio and ranking #10 among its reported holdings. Lynx1 Capital Management LP has disclosed PASG holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)673.76K sh
Reported value held$3.29M
Portfolio Weight0.38%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's PASG position evolved

Lynx1 Capital Management LP first disclosed a stake in PASG in Q3 2023 at 190,124 shares (US$125K). The position peaked in Q4 2025 at 623,704 shares, worth US$7.4M. Across 12 filings, Lynx1 Capital Management LP increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 673,759 shares valued at US$3.3M — an increase of 50,055 shares quarter over quarter.. Notable position changes include a 99% increase in Q4 2023 (shares rose 34% over the following quarter), a 1178% increase in Q1 2024 (shares fell 41% over the following quarter), a 93% trim in Q3 2025 (shares rose 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 190.12K $125.10K New
Q4 2023 379.16K $382.95K Add
Q1 2024 4.85M $6.54M Add
Q2 2024 5.06M $4.02M Add
Q3 2024 8.43M $5.90M Add
Q4 2024 9.26M $5.25M Add
Q1 2025 9.26M $3.27M Hold
Q2 2025 9.26M $3.71M Hold
Q3 2025 623.70K $5.01M Reduce
Q4 2025 623.70K $7.36M Hold
Q1 2026 623.70K $4.90M Hold
Q2 2026 673.76K $3.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PASG and 13F data

PASG (Passage Bio Inc) is a Health Care company. 18 other funds we track also report a position in PASG — the largest reported positions include Yiheng Capital Management, L.P. (US$420K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PASG

All PASG fund holders →

FAQ

How long has Lynx1 Capital Management LP held PASG?

Lynx1 Capital Management LP has disclosed PASG holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Lynx1 Capital Management LP's current position in PASG?

As of Q2 2026, Lynx1 Capital Management LP holds 673.76K shares of PASG (Passage Bio Inc), valued at $3.29M, representing 0.38% of its reported portfolio and ranking #10.

Has Lynx1 Capital Management LP been buying or selling PASG?

In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP increased its position in PASG. The position peaked in Q4 2025 at 623.70K shares.

Which other funds hold PASG?

Other major institutional holders of PASG include Yiheng Capital Management, L.P., among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.